ReviewCancer chemotherapy and pharmacology2025
Curcumin in colorectal cancer: preventive strategies and therapeutic mechanisms.
Review in Cancer chemotherapy and pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is a leading global cause of cancer-related deaths, influenced by both genetic predisposition and lifestyle factors. Inherited syndromes such as Lynch syndrome and Familial Adenomatous Polyposis account for a minority of cases, while modifiable risk factors like diet, obesity, smoking, and physical inactivity significantly contribute to incidence rates. Curcumin, a natural polyphenol derived from turmeric, has garnered interest due to its anti-inflammatory and anticancer properties, particularly in CRC prevention and therapy. Despite promising preclinical data, challenges such as poor bioavailability hinder its clinical translation. Innovative delivery systems are under development to enhance its therapeutic potential. This review explores CRC's epidemiology, risk factors, current treatments, and curcumin's emerging role in management strategies.
Indexed as
Identifiers
41460258What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.